Vorasidenib,1644545-52-7

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Vorasidenib

CAS No. : 1644545-52-7

MCE 国际站：Vorasidenib

产品活性：Vorasidenib (AG-881) 是一种可口服的、脑渗透的第二代突变体异柠檬酸脱氢酶 1 和 2 (mIDH1/2) 双重抑制剂。Vorasidenib (AG-881) 以纳摩尔抑制 D-2-HG，对 IDH1 R132C、IDH1 R132G、IDH1 R132H、IDH1 R132S 的 IC₅₀ 值为 0.04~22 nM，对 IDH2 R140Q 值为 7~14 nM，对 IDH2 R172K 的值为 130 nM。

研究领域：Metabolic Enzyme/Protease

作用靶点：Isocitrate Dehydrogenase (IDH)

In Vitro: Vorasidenib 对人胶质母细胞瘤 U-87 MG pLVX-IDH2 R140Q-neo、纤维肉瘤 HT-1080 和神经球 TS603 细胞具有很强的抗增殖活性，IC₅₀ 均小于 50 nM。

相关产品：Covalent Screening Library Plus  |  Drug Repurposing Compound Library Plus  |  Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  Metabolism/Protease Compound Library  |  Anti-Cancer Compound Library  |  Clinical Compound Library  |  CNS-Penetrant Compound Library  |  Drug Repurposing Compound Library  |  Covalent Screening Library  |  Orally Active Compound Library  |  Glutamine Metabolism Compound Library  |  Anti-Cancer Metabolism Compound Library  |  Mitochondria-Targeted Compound Library  |  Glucose Metabolism Compound Library  |  Rare Diseases Drug Library  |  Heterocyclic Compound Library  |  TCA Cycle Compound Library  |  Ivosidenib  |  Enasidenib  |  AGI-6780  |  GSK864  |  AGI-5198  |  BAY-1436032  |  IDH-305  |  Olutasidenib  |  Mutant IDH1-IN-1  |  DS-1001b  |  GSK321  |  (R,R)-GSK321  |  IDH1 Inhibitor 2  |  Mutant IDH1 inhibitor  |  IDH889  |  IDH1 Inhibitor 7  |  IDH1 Inhibitor 1  |  Mutant IDH1-IN-2  |  AGI-12026  |  Alternaphenol B2  |  IDH-C227  |  IDH1 Inhibitor 3  |  IDH1 Inhibitor 5

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds